...
首页> 外文期刊>Phytochemistry >Discrimination of different geographic varieties of Gymnema sylvestre, an anti-sweet plant used for the treatment of type 2 diabetes
【24h】

Discrimination of different geographic varieties of Gymnema sylvestre, an anti-sweet plant used for the treatment of type 2 diabetes

机译:鉴别Mymnema Sylvestre的不同地理品种,一种用于治疗2型糖尿病的抗甜植物

获取原文
获取原文并翻译 | 示例
           

摘要

Gymnema sylvestre (Retz.) R.Br. ex Sm. (Asclepiadaceae) is a well-known Ayurvedic anti-sweet plant for the treatment of type 2 diabetes mellitus. Although it was previously proposed that G. sylvestre exhibits chemical variation based on geography, most research on G. sylvestre has used material originating from India. Morphological and anatomical descriptions, ITS1-5.8S-ITS2 DNA sequencing, and acid hydrolysis analyses showed that G. sylvestre samples from Vietnam are distinguishable from those of Indian origin and thus suggest a dissimilarity among G. sylvestre samples with different geographic distributions. An LC-MS-guided strategy targeting 3 beta-glucuronide oleane-triterpenes in the Vietnamese G. sylvestre variety led to the isolation of four known compounds and nine previously undescribed compounds, named gymnemosides ND1-ND9. None of the isolated compounds were reported in the Indian sample, further supporting the geo-diversity of G. sylvestre. Three compounds, gymnemosides ND7-9, exerted significant stimulatory effects on the uptake of 2-NBDG in 3T3-L1 adipocyte cells and thus have potential as lead molecules for anti-diabetes agents. (C) 2018 Elsevier Ltd. All rights reserved.
机译:Gymnema Sylvestre(Retz。)R.Br. EX SM。 (Asclepiadaceae)是一家着名的阿育吠陀抗甜植物,用于治疗2型糖尿病。虽然先前提出了G. Sylvestre在地理上表现出化学变化,但大多数关于G. Sylvestre的研究已经使用了来自印度的材料。形态学和解剖学描述,其1-5.8S-ITS2 DNA测序和酸水解分析表明,来自越南的G. Sylvestre样本与印度起源的斯文利人不同,因此表明G. Sylvestre样本中具有不同地理分布的样本。 LC-MS引导策略靶向越南G.Sylvestre品种中的3β-葡萄糖蛋白酶Oleane-Triterpenes,LED为四种已知的化合物和九个以前未描述的化合物,名为Gymnemosides ND1-ND9。印度样本中没有报道分离的化合物,进一步支持G. Sylvestre的地质多样性。三种化合物,Gymnemosides ND7-9,对3T3-L1 adipocyte细胞的2-NBDG的摄取产生了显着的刺激作用,因此具有抗糖尿病药剂的铅分子。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号